Tumor PD-L1 Triggers β2m Degradation to Evade Immunity
In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by ...
In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by ...
In a remarkable advancement in cancer research, a team of scientists led by Zhang et al. has unveiled critical insights ...
Immune-checkpoint inhibitors (ICIs) have emerged as a transformative approach in the treatment landscape of various solid tumors. Among these, agents ...
In a groundbreaking advance that reshapes our understanding of tumor biology and immune evasion, a team of researchers has unraveled ...
In a groundbreaking discovery that may revolutionize the future of cancer immunotherapy, researchers at the UC Davis Comprehensive Cancer Center ...
Immunotherapy has revolutionized cancer treatment by harnessing the body's own immune system to identify and eradicate malignant cells. Among the ...
For nearly 40 years, erythropoietin (EPO) has been recognized primarily for its role in stimulating red blood cell production, a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine